ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW?
The beta-blocker role in arterial hypertension treatment is surveyed from the positions of evidence based medicine and international clinical guidelines. Data of last randomized clinical trials and meta-analyses are discussed.
Main Author: | S. Y. Martsevich |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1120 |
Similar Items
-
ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT?
by: S. Y. Martsevich
Published: (2016-01-01) -
Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers
by: V. N. Larina, et al.
Published: (2021-11-01) -
BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01) -
BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
by: M. V. Leonova
Published: (2015-12-01) -
Prospective follow-up of nebivolol in the treatment of arterial hypertension
by: Despotović Nebojša, et al.
Published: (2012-01-01)